RETAIN: A Phase 2/3 Randomized, Placebo-Controlled Study to Evaluate the Efficacy of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Total Knee Arthroplasty (TKA) (RETAIN)

Principal Investigator

Dr Abtin Alvand

Contact us

Email: gail.lang@ndorms.ox.ac.uk

IRAS number

1013306